The deal size was reduced to $65M in common stock from $125M in common stock. JPMorgan, Jefferies and Cowen acted as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVAX:
- Novavax put volume heavy and directionally bearish
- Novavax (NASDAQ:NVAX) Stock Sinks on Stock Offering, U.K. Vaccine Deal
- Novavax reaffirms FY22 revenue guidance approximately $2B, consensus $2.1B
- Novavax announces $125M common stock offering
- Novavax call volume above normal and directionally bullish